Changsheng® is the commercial brand name of Cefotaxime Sodium and Tazobactam Sodium for Injection, a combination antibacterial product developed by Xiangbei Welman Pharmaceutical Co., Ltd. Cefotaxime is a third-generation cephalosporin that inhibits bacterial cell wall synthesis; tazobactam is a beta-lactamase…
Heyiding® is the commercial brand name of Ceftazidime for Injection and 5% Glucose Injection, a third-generation cephalosporin antibiotic developed by Hunan Kelun Pharmaceutical Co., Ltd. It exerts bactericidal effect by inhibiting the synthesis of bacterial cell wall, with stable activity…
Heyirui® is the commercial brand name of Imipenem and Cilastatin Sodium for Injection and Sodium Chloride Injection, a carbapenem antibacterial agent developed by Hunan Kelun Pharmaceutical Co., Ltd. Imipenem inhibits bacterial cell wall synthesis with broad-spectrum bactericidal activity; cilastatin prevents…
Zexing® is the commercial brand name of Landiolol Hydrochloride for Injection, an ultra-short-acting β1-selective adrenoceptor blocker developed by Nanjing Hicin Pharmaceutical Co., Ltd. It competitively blocks cardiac β1 receptors to rapidly reduce heart rate and blood pressure, with fast onset…
Kailikang® is the commercial brand name of Urinary Kallidinogenase for Injection, a human urinary kallidinogenase developed by Techpool Bio-Pharma Co., Ltd. It converts kininogen into kinin, dilates cerebral vessels, improves cerebral microcirculation, promotes angiogenesis and reduces neurological deficits in ischemic…
Aolirui® is the commercial brand name of Dexlansoprazole for Injection, a proton pump inhibitor developed by Jiangsu Aosaikang Pharmaceutical. It suppresses gastric acid secretion by irreversibly inhibiting the H+/K+-ATPase on gastric parietal cells, raising intragastric pH rapidly and persistently. Main…
Mingfule® is the commercial brand name of Recombinant Human TNK Tissue-type Plasminogen Activator for Injection, a genetically engineered tissue plasminogen activator developed by CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd. It selectively converts plasminogen to plasmin at the thrombus site to…
Xinhuosu® is the commercial brand name of Recombinant Human Brain Natriuretic Peptide for Injection, a recombinant peptide drug developed by Tibet Rhodiola Pharmaceutical. It vasodilates blood vessels, inhibits the renin‑angiotensin‑aldosterone system, promotes natriuresis and diuresis, and reduces cardiac preload and…
NovoSeven® is the commercial brand name of Recombinant Coagulation Factor VIIa for Injection, a recombinant activated coagulation factor developed by Novo Nordisk. It binds to exposed tissue factor at bleeding sites to activate factor X and accelerate thrombin generation, thereby…
Zisheng® is the commercial brand name of Paclitaxel Polymeric Micelles for Injection, an innovative solvent-free paclitaxel formulation developed by Shanghai Yizhong Pharmaceutical. It exerts anti-tumor activity by promoting microtubule polymerization and inhibiting tumor cell mitosis. The polymeric micelle carrier removes…